Trials / Unknown
UnknownNCT03794115
Immune Repertoire of Ovarian HGSC
Differential Expression of Immune Repertoire of T/B Lymphocytes in Ovarian High Grade Serous Carcinoma
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Lei Li · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this preliminary study, peripheral blood and carcinoma tissue with pericarcinomatous tissue are taken from the patients with ovarian high grade serous carcinoma at several points: before any treatment, after the debulking surgery, and after all the proposed chemotherapy. The differential expression of the T/B lymphocyte receptors in these samples will be analyzed with the platinum-based treatment and survival outcomes of the patients. The primary objective is the expression rates of T/B lymphocyte receptors in different stages of checking points.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Treatment for ovarian cancer | The treatment for ovarian cancer includes the debulking surgery and platinum-based chemotherapy. |
Timeline
- Start date
- 2019-01-03
- Primary completion
- 2021-01-01
- Completion
- 2022-01-01
- First posted
- 2019-01-04
- Last updated
- 2019-01-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03794115. Inclusion in this directory is not an endorsement.